Provention Bio Inc. (PRVB) Tops Q1 EPS by 11c

Provention Bio Inc. (NASDAQ: PRVB) reported Q1 EPS of ($0.35), $0.11 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $580 thousand versus the consensus estimate of $700 thousand.

For earnings history and earnings-related data on Provention Bio Inc. (PRVB) click here.

You May Also Be Interested In

• Coherent posts a blowout Q4 and aggressive guidance, yet shares take a 5% haircut
• Direct Digital Holdings (DRCT) Misses Q2 EPS by 158c
• Grocery Outlet Holding Corp. (GO) Tops Q2 EPS by 8c, Offers Guidance